What is the point of the LV delivery on a 17a oral? They're already readily available and do not need any further assistance for adequate delivery. This kind of technology is promising for non-17a substances, but for said DS, it is overkill. Also, as John stated, the time/investment would not warrant the return for PP considering the uncertainty surrounding these products.